Chawla Lakhmir S Insider Trades

Insider Trading History

Track insider trading activity for Chawla Lakhmir S. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Revelation Biosciences- Warrants(10/01/2027)
Revelation Biosciences- Warrants(10/01/2027) REVBW
Director
Holding Value $167 12,158 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26 2,261 shares
$0.01
$0.01
Revelation Biosciences
Revelation Biosciences REVB
Director
Holding Value $12.6k 12,158 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.18k 2,261 shares
$1.85
$1.04
Revelation Biosciences- Units (1 Ord share & 1 War)
Revelation Biosciences- Units (1 Ord share & 1 War) REVBU
Director
Holding Value $3.52k 12,158 shares
Last Trade
Feb 03, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$655 2,261 shares
$0.29
$0.29
Revelation Biosciences- Units (1 Ord share & 1 War)
Revelation Biosciences- Units (1 Ord share & 1 War) REVBU
Director
Holding Value $16.7k 57,667 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.2k 41,981 shares
$0.29
$0.29
Revelation Biosciences- Warrants(10/01/2027)
Revelation Biosciences- Warrants(10/01/2027) REVBW
Director
Holding Value $790 57,667 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$340 41,981 shares
$0.01
$0.01
Revelation Biosciences
Revelation Biosciences REVB
Director
Holding Value $60k 57,667 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 41,981 shares
$3.60
$1.04
Revelation Biosciences
Revelation Biosciences REVB
Director
Holding Value $16.3k 15,686 shares
Last Trade
Oct 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80k 15,625 shares
$5.12
$1.04
Revelation Biosciences- Warrants(10/01/2027)
Revelation Biosciences- Warrants(10/01/2027) REVBW
Director
Holding Value $215 15,686 shares
Last Trade
Oct 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194 15,625 shares
$0.01
$0.01
Revelation Biosciences- Units (1 Ord share & 1 War)
Revelation Biosciences- Units (1 Ord share & 1 War) REVBU
Director
Holding Value $4.54k 15,686 shares
Last Trade
Oct 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.53k 15,625 shares
$0.29
$0.29
Revelation Biosciences- Warrants(10/01/2027)
Revelation Biosciences- Warrants(10/01/2027) REVBW
Director
Holding Value $2.48 181 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.33 181 shares
$0.02
$0.01
Revelation Biosciences- Units (1 Ord share & 1 War)
Revelation Biosciences- Units (1 Ord share & 1 War) REVBU
Director
Holding Value $52.4 181 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.4 181 shares
$0.29
$0.29
Revelation Biosciences
Revelation Biosciences REVB
Director
Holding Value $188 181 shares
Last Trade
Feb 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$700 181 shares
$3.87
$1.04
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $83.2k 13,447 shares
Last Trade
Sep 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.4k 572 shares
$4.19
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $81.5k 13,161 shares
Last Trade
Aug 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28k 1,100 shares
$3.89
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $78.1k 12,611 shares
Last Trade
Aug 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.29k 1,178 shares
$3.64
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $74.4k 12,022 shares
Last Trade
Jul 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28k 1,162 shares
$3.68
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $70.8k 11,441 shares
Last Trade
Jul 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28k 1,042 shares
$4.11
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $371k 60,000 shares
Last Trade
Jul 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$271k 60,000 shares
$4.52
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $67.6k 10,920 shares
Last Trade
Jun 30, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.28k 1,086 shares
$3.94
$6.19
La Jolla Pharmaceutical
La Jolla Pharmaceutical LJPC
Chief Medical Officer
Holding Value $64.2k 10,377 shares
Last Trade
Jun 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.27k 870 shares
$4.91
$6.19

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up